Audit of primary tumors in oculoplastic cases at a tertiary care centre in North India

---

Review Article

Author Details : Priyanka Gupta, Ramesh Chandra Gupta, Shalini Mohan, R.N.S. Kushwaha, Brijesh Thakur

Volume : 4, Issue : 1, Year : 2018

Article Page : 22-26

https://doi.org/10.18231/2455-8478.2018.0008

Suggest article by email

Get Permission

---

Abstract

Introduction: There is geographical variation in pattern of ocular tumors. We aimed to identify and describe the clinicopathologic characteristics of primary tumors of the eye and ocular adnexa in oculoplastic clinics at our tertiary care centre.
Materials and Methods: In our prospective longitudinal study patients with primary ocular tumors underwent surgical management. Resectable tumors were subjected to excision biopsy. Incision biopsy was taken in advanced malignant tumors.  The tissue masses were sent for histopathological examination. Cases were followed up monthly to see recurrences.
Result: Out of 676 oculoplastic cases operated, 68 patients required surgery for tumors with common site being upper eyelid followed by periorbital area & lower eyelid. 75% cases were benign while 25% were malignant. Maximum cases in benign group were in the age group 11-20 year & in malignant group in age group of 41-50 years. Recurrence rate was 17.3%. Sebaceous cell carcinoma (44.4%) was the predominant malignant eyelid tumor.
Conclusion: We observed an interesting geographical variation in malignant eyelid tumor. We have come up with a few recommendations to prevent recurrences.

Keywords: Benign, Malignant, Ocular tumors, Oculoplastic cases.

How to cite : Gupta P, Gupta R C, Mohan S, Kushwaha R, Thakur B, Audit of primary tumors in oculoplastic cases at a tertiary care centre in North India. IP Int J Ocul Oncol Oculoplasty 2018;4(1):22-26

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.